{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T14:03:20Z","timestamp":1766153000699,"version":"3.48.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019822","name":"Institute for Clinical and Translational Research, University of Maryland, Baltimore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jtha.2025.08.014","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T23:30:03Z","timestamp":1756855803000},"page":"3757-3768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Alternate functions of physiological anticoagulants"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7419-9241","authenticated-orcid":false,"given":"Teagan","family":"Prouse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan E.","family":"Mast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Ignjatovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana","family":"Kovac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsuzsanna","family":"Bereczky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinku","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.08.014_bib1","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.3390\/ijms22084283","article-title":"Antithrombin and its role in host defense and inflammation","volume":"22","author":"Schl\u00f6mmer","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2025.08.014_bib2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1160\/TH15-08-0687","article-title":"Antithrombin: anti-inflammatory properties and clinical applications","volume":"115","author":"Levy","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/ALN.0000000000001428","article-title":"Activated protein C drives the hyperfibrinolysis of acute traumatic coagulopathy","volume":"126","author":"Davenport","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtha.2025.08.014_bib4","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1046\/j.1538-7836.2003.00443.x","article-title":"Activated protein C attenuates coagulation-associated over-expression of fibrinolytic activity by suppressing the thrombin-dependent inactivation of PAI-1","volume":"1","author":"Urano","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib5","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/jth.15732","article-title":"Diagnosis and management of severe congenital protein C deficiency (SCPCD): communication from the SSC of the ISTH","volume":"20","author":"Minford","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib6","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202401128R","article-title":"Platelets at the intersection of inflammation and coagulation in the APC-mediated response to myocardial ischemia\/reperfusion injury","volume":"38","author":"Slotabec","year":"2024","journal-title":"FASEB J"},{"key":"10.1016\/j.jtha.2025.08.014_bib7","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1182\/blood-2009-11-256610","article-title":"Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain","volume":"115","author":"Andersson","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.08.014_bib8","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1016\/S0021-9258(19)70660-7","article-title":"Regulation of activated protein C by a new protein. A possible function for bovine protein S","volume":"255","author":"Walker","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.08.014_bib9","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1016\/S0021-9258(18)90969-5","article-title":"Regulation of vitamin K-dependent protein S. Inactivation by thrombin","volume":"259","author":"Walker","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.08.014_bib10","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/ATVBAHA.108.177436","article-title":"Protein S as cofactor for TFPI","volume":"29","author":"Hackeng","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.08.014_bib11","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.0504240103","article-title":"Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor","volume":"103","author":"Hackeng","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2025.08.014_bib12","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1161\/ATVBAHA.112.250928","article-title":"Inhibition of intrinsic Xase by protein S: a novel regulatory role of protein S independent of activated protein C","volume":"32","author":"Chattopadhyay","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.08.014_bib13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/ATVBAHA.117.310588","article-title":"Anticoagulant protein S targets the factor IXa heparin-binding exosite to prevent thrombosis","volume":"38","author":"Plautz","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.08.014_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MOH.0000000000000663","article-title":"Protein S: function, regulation, and clinical perspectives","volume":"28","author":"Majumder","year":"2021","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jtha.2025.08.014_bib15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood.V78.2.394.394","article-title":"Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor","volume":"78","author":"Novotny","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.08.014_bib16","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood.V72.6.2020.2020","article-title":"Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor","volume":"72","author":"Novotny","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.08.014_bib17","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/ATVBAHA.120.315728","article-title":"Major reservoir for heparin-releasable TFPI\u03b1 (tissue factor pathway inhibitor \u03b1) is extracellular matrix","volume":"41","author":"Peterson","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.08.014_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-0037-1614416","article-title":"TFPI\u03b2, a second product from the mouse tissue factor pathway inhibitor (TFPI) gene","volume":"81","author":"Chang","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105032","article-title":"A systems pharmacokinetic\/pharmacodynamic model for concizumab to explore the potential of anti-TFPI recycling antibodies","volume":"138","author":"Yuan","year":"2019","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jtha.2025.08.014_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/ATVBAHA.115.305996","article-title":"Tissue factor pathway inhibitor: multiple anticoagulant activities for a single protein","volume":"36","author":"Mast","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2025.08.014_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211063877","article-title":"The impact of anticoagulant activity of tissue factor pathway inhibitor measured by a novel functional assay for predicting deep venous thrombosis in trauma patients: a prospective nested case-control study","volume":"27","author":"Cao","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/10760296241296138","article-title":"Vascular endothelial dysfunction and immunothrombosis in the pathogenesis of atrial fibrillation","volume":"30","author":"Dungan","year":"2024","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib23","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1177\/0961203311418267","article-title":"Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus","volume":"20","author":"Adams","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.jtha.2025.08.014_bib24","doi-asserted-by":"crossref","first-page":"442","DOI":"10.5114\/ada.2019.87447","article-title":"Evaluation of plasma levels of tissue factor and tissue factor pathway inhibitor in patients with psoriasis","volume":"36","author":"Domaga\u0142a","year":"2019","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.jtha.2025.08.014_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3892\/mco.2021.2479","article-title":"Tissue factor pathway inhibitor 2 as a serum marker for diagnosing asymptomatic venous thromboembolism in patients with epithelial ovarian cancer and positive D-dimer results","volume":"16","author":"Miyake","year":"2022","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.jtha.2025.08.014_bib26","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1172\/JCI69091","article-title":"Coagulation factor VA2440G causes east Texas bleeding disorder via TFPI\u03b1","volume":"123","author":"Vincent","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2025.08.014_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/09537104.2021.1913576","article-title":"Release of \u03b1-granule contents during platelet activation","volume":"33","author":"Smith","year":"2022","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2025.08.014_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1160\/TH12-08-0622","article-title":"Platelet protein S directly inhibits procoagulant activity on platelets and microparticles","volume":"109","author":"Stavenuiter","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib29","doi-asserted-by":"crossref","first-page":"21051","DOI":"10.1016\/S0021-9258(17)31928-2","article-title":"Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa","volume":"269","author":"Hackeng","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.08.014_bib30","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood.V66.6.1452.1452","article-title":"Identification and quantitation of protein S in human platelets","volume":"66","author":"Schwarz","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.08.014_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100733","article-title":"Interplay between platelets and coagulation","volume":"46","author":"Sang","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2025.08.014_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bpj.2022.10.038","article-title":"Inhibition of platelet-surface-bound proteins during coagulation under flow II: antithrombin and heparin","volume":"122","author":"Miyazawa","year":"2023","journal-title":"Biophys J"},{"key":"10.1016\/j.jtha.2025.08.014_bib33","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1160\/th15-04-0354","article-title":"Role of exosite binding modulators in the inhibition of Fxa by TFPI","volume":"115","author":"Peraramelli","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib34","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1182\/blood.2019002771","article-title":"The protein C activator AB002 rapidly interrupts thrombus development in baboons","volume":"135","author":"Tucker","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.08.014_bib35","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1538-7836.2008.02979.x","article-title":"Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor 2","volume":"6","author":"White","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib36","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/jth.14165","article-title":"Human platelets express endothelial protein C receptor, which can be utilized to enhance localization of factor VIIa activity","volume":"16","author":"Fager","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810203","article-title":"Coagulation factor XIIIa and activated protein C activate platelets via GPVI and PAR1","volume":"23","author":"De Simone","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2025.08.014_bib38","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1111\/jth.14594","article-title":"The roles of factor Va and protein S in formation of the activated protein C\/protein S\/factor Va inactivation complex","volume":"17","author":"Gierula","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib39","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.2019003630","article-title":"Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus","volume":"135","author":"Calzavarini","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.08.014_bib40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1182\/blood.V74.1.213.213","article-title":"Familial protein S deficiency with a variant protein S molecule in plasma and platelets","volume":"74","author":"Schwarz","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.08.014_bib41","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1538-7836.2008.02980.x","article-title":"Protein S enhances the tissue factor pathway inhibitor inhibition of factor Xa but not its inhibition of factor VIIa-tissue factor","volume":"6","author":"Ndonwi","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib42","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/jth.15697","article-title":"Regulation of coagulation by tissue factor pathway inhibitor: implications for hemophilia therapy","volume":"20","author":"Mast","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib43","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1172\/JCI71220","article-title":"Factor V, tissue factor pathway inhibitor, and east Texas bleeding disorder","volume":"123","author":"Broze","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2025.08.014_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bpj.2022.11.023","article-title":"Inhibition of platelet-surface-bound proteins during coagulation under flow I: TFPI","volume":"122","author":"Miyazawa","year":"2023","journal-title":"Biophys J"},{"key":"10.1016\/j.jtha.2025.08.014_bib45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.thromres.2023.08.012","article-title":"Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation","volume":"230","author":"Li","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.08.014_bib46","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jtha.2022.11.034","article-title":"Platelet tissue factor pathway inhibitor-\u03b1 dampens cardiac thrombosis and associated fibrosis in mice","volume":"21","author":"Maroney","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib47","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211372","article-title":"Protection of ischemic white matter and oligodendrocytes in mice by 3K3A-activated protein C","volume":"219","author":"Huuskonen","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.jtha.2025.08.014_bib48","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/TA.0000000000004170","article-title":"Trauma-induced coagulopathy: what you need to know","volume":"96","author":"Buzzard","year":"2024","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.jtha.2025.08.014_bib49","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/TA.0000000000003000","article-title":"Antithrombin III ameliorates post-traumatic brain injury cerebral leukocyte mobilization enhancing recovery of blood brain barrier integrity","volume":"90","author":"ElSaadani","year":"2021","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.jtha.2025.08.014_bib50","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/TA.0000000000003112","article-title":"Post-traumatic brain injury antithrombin III recovers Morris water maze cognitive performance, improving cued and spatial learning","volume":"91","author":"ElSaadani","year":"2021","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.jtha.2025.08.014_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.hemonc.2018.09.005","article-title":"Early posttraumatic changes in coagulation and fibrinolysis systems in isolated severe traumatic brain injury patients and its influence on immediate outcome","volume":"12","author":"Albert","year":"2019","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jtha.2025.08.014_bib52","article-title":"Activated protein C signaling mediates neuroinflammation in seizure induced by pilocarpine","volume":"35","author":"Zoungrana","year":"2023","journal-title":"Biochem Biophys Rep"},{"key":"10.1016\/j.jtha.2025.08.014_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820917288","article-title":"Neuroprotective effect of activated protein C on blood-brain barrier injury during focal cerebral ischemia\/reperfusion","volume":"18","author":"Wang","year":"2020","journal-title":"Dose Response"},{"key":"10.1016\/j.jtha.2025.08.014_bib54","first-page":"1254","article-title":"Early coagulopathy after traumatic brain injury: the role of hypoperfusion and the protein C pathway","volume":"63","author":"Cohen","year":"2007","journal-title":"J Trauma"},{"issue":"20 Suppl 2","key":"10.1016\/j.jtha.2025.08.014_bib55","first-page":"S6","article-title":"Global epidemiology of stroke and access to acute ischemic stroke interventions","volume":"97","author":"Saini","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.jtha.2025.08.014_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11910-009-0076-8","article-title":"Evolution of the thrombolytic treatment window for acute ischemic stroke","volume":"10","author":"Stemer","year":"2010","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jtha.2025.08.014_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.593582","article-title":"Stroke treatment with PAR-1 agents to decrease hemorrhagic transformation","volume":"12","author":"Lyden","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.jtha.2025.08.014_bib58","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1161\/STROKEAHA.120.028793","article-title":"3K3A-Activated protein C variant does not interfere with the plasma clot lysis activity of tenecteplase","volume":"51","author":"Mukherjee","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.08.014_bib59","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.3390\/genes13112081","article-title":"Factor V Leiden, Factor II, protein C, protein S, and antithrombin and ischemic strokes in young adults: a meta-analysis","volume":"13","author":"Tsalta-Mladenov","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jtha.2025.08.014_bib60","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.2147\/JIR.S428589","article-title":"An exploration of anti-inflammatory therapy in acute\/subacute severe cerebral venous thrombosis with hereditary protein C\/S deficiency: case series","volume":"16","author":"Hao","year":"2023","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jtha.2025.08.014_bib61","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1160\/TH16-08-0615","article-title":"Cancer-associated venous thromboembolism: burden, mechanisms, and management","volume":"117","author":"Ay","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib62","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1055\/s-0043-1771270","article-title":"Ischemic stroke in cancer: mechanisms, biomarkers, and implications for treatment","volume":"50","author":"Costamagna","year":"2024","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","article-title":"Cancer-associated venous thromboembolism","volume":"8","author":"Khorana","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jtha.2025.08.014_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415770","article-title":"Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer","volume":"23","author":"Englisch","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2025.08.014_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271663","article-title":"Low antithrombin levels are associated with low risk of cardiovascular death but are a risk factor for cancer mortality","volume":"17","author":"Iacoviello","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2025.08.014_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108332","article-title":"Structural alteration in hypochlorous acid modified antithrombin indicates generation of neo-epitopes","volume":"685","author":"Ahmad","year":"2020","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jtha.2025.08.014_bib67","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1186\/s12885-020-07375-2","article-title":"Antithrombin use and mortality in patients with stage IV solid tumor-associated disseminated intravascular coagulation: a nationwide observational study in Japan","volume":"20","author":"Taniguchi","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtha.2025.08.014_bib68","first-page":"1128","article-title":"Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer","volume":"109","author":"Englisch","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.08.014_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123227","article-title":"Glioblastoma therapy: state of the field and future prospects","volume":"359","author":"Khiabani","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.jtha.2025.08.014_bib70","first-page":"1152","article-title":"Neutrophil-to-lymphocyte ratio, factor VIII and antithrombin III: inflammatory-clotting biomarkers in glioma","volume":"20","author":"Koudriavtseva","year":"2021","journal-title":"EXCLI J"},{"key":"10.1016\/j.jtha.2025.08.014_bib71","article-title":"PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2025.08.014_bib72","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12967-022-03536-y","article-title":"LncRNA RP3-525N10.2-NFKB1-PROS1 triplet-mediated low PROS1 expression is an onco-immunological biomarker in low-grade gliomas: a pan-cancer analysis with experimental verification","volume":"20","author":"Zhou","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.jtha.2025.08.014_bib73","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/biom11050663","article-title":"Imbalance in coagulation\/fibrinolysis inhibitors resulting in extravascular thrombin generation in gliomas of varying levels of malignancy","volume":"11","author":"Wojtukiewicz","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jtha.2025.08.014_bib74","first-page":"1106","article-title":"Hypercoagulability state combined with post-treatment hypofibrinolysis in invasive breast cancer: a seven-year follow-up evaluating disease-free and overall survival","volume":"13","author":"Wrzeszcz","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.jtha.2025.08.014_bib75","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1186\/s12885-017-3719-1","article-title":"Venous thromboembolism and mortality in breast cancer: cohort study with systematic review and meta-analysis","volume":"17","author":"Khan","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtha.2025.08.014_bib76","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1074\/jbc.M117.814046","article-title":"Protein C receptor stimulates multiple signaling pathways in breast cancer cells","volume":"293","author":"Wang","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtha.2025.08.014_bib77","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.yexcr.2006.11.019","article-title":"Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1","volume":"313","author":"Beaulieu","year":"2007","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jtha.2025.08.014_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110918","article-title":"PROS1, a clinical prognostic biomarker and tumor suppressor, is associated with immune cell infiltration in breast cancer: a bioinformatics analysis combined with experimental verification","volume":"112","author":"He","year":"2023","journal-title":"Cell Signal"},{"key":"10.1016\/j.jtha.2025.08.014_bib79","doi-asserted-by":"crossref","DOI":"10.1172\/JCI126089","article-title":"Myeloid cell-derived PROS1 inhibits tumor metastasis by regulating inflammatory and immune responses via IL-10","volume":"131","author":"Maimon","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2025.08.014_bib80","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13058-015-0548-5","article-title":"Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF","volume":"17","author":"Tinholt","year":"2015","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.jtha.2025.08.014_bib81","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3390\/cells12060910","article-title":"The heparan sulfate proteoglycan syndecan-1 triggers breast cancer cell-induced coagulability by induced expression of tissue factor","volume":"12","author":"Hassan","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jtha.2025.08.014_bib82","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s13258-022-01258-5","article-title":"TFPI inhibits breast cancer progression by suppressing ERK\/p38 MAPK signaling pathway","volume":"44","author":"Xing","year":"2022","journal-title":"Genes Genomics"},{"key":"10.1016\/j.jtha.2025.08.014_bib83","first-page":"116","article-title":"Thrombophilia and unexplained pregnancy loss in Indian patients","volume":"21","author":"Vora","year":"2008","journal-title":"Natl Med J India"},{"key":"10.1016\/j.jtha.2025.08.014_bib84","doi-asserted-by":"crossref","first-page":"160","DOI":"10.25122\/jml-2022-0267","article-title":"Investigating protein C and S levels in pregnant women with recurrent early pregnancy loss versus normal pregnancy","volume":"16","author":"Mukhtar","year":"2023","journal-title":"J Med Life"},{"key":"10.1016\/j.jtha.2025.08.014_bib85","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12959-024-00581-z","article-title":"Thrombosis-related characteristics of pregnant women with antithrombin deficiency, protein C deficiency and protein S deficiency in Japan","volume":"22","author":"Kobayashi","year":"2024","journal-title":"Thromb J"},{"key":"10.1016\/j.jtha.2025.08.014_bib86","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1016\/S2352-3026(20)30007-7","article-title":"Risk of pregnancy-related venous thromboembolism and obstetrical complications in women with inherited type I antithrombin deficiency: a retrospective, single-centre, cohort study","volume":"7","author":"Abbattista","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2025.08.014_bib87","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1016\/S2352-3026(20)30038-7","article-title":"Antithrombin deficiency in pregnancy-the unresolved issues","volume":"7","author":"Kovac","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2025.08.014_bib88","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.thromres.2018.11.006","article-title":"The influence of specific mutations in the AT gene (SERPINC1) on the type of pregnancy related complications","volume":"173","author":"Kovac","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.08.014_bib89","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00277-017-2965-2","article-title":"Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complications","volume":"96","author":"Kraft","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtha.2025.08.014_bib90","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.jtha.2025.01.015","article-title":"How we treat severe inherited antithrombin deficiency: lessons from cases homozygous for the Budapest 3 variant","volume":"23","author":"Bravo-P\u00e9rez","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000484514","article-title":"Reduced protein C global assay levels in infertile women with in vitro fertilization failure: a pilot study","volume":"139","author":"El Masry","year":"2018","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jtha.2025.08.014_bib92","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1080\/01443615.2022.2113509","article-title":"Activated protein C resistance impact on Syrian candidates for in vitro fertilisation and the benefit of anticoagulation therapy: a retrospective cohort study","volume":"42","author":"Sabouni","year":"2022","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.jtha.2025.08.014_bib93","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11239-021-02513-4","article-title":"Inhibitory effects of amniotic fluid on the activated protein C anticoagulation system in maternal plasma","volume":"53","author":"Jain","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2025.08.014_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MBC.0000000000001269","article-title":"Increased contact activated endogenous thrombin potential in pregnant women with preeclampsia","volume":"35","author":"Godtfredsen","year":"2024","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2025.08.014_bib95","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201150R","article-title":"Endothelial protein C receptor is increased in preterm preeclampsia and fetal growth restriction","volume":"36","author":"Andres","year":"2022","journal-title":"FASEB J"},{"key":"10.1016\/j.jtha.2025.08.014_bib97","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.35","article-title":"HIV infection","volume":"1","author":"Deeks","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jtha.2025.08.014_bib98","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12288-021-01440-x","article-title":"Analysis of the coagulation profile in children with HIV infection-effect of disease and anti retroviral therapy","volume":"38","author":"Thomas","year":"2022","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.jtha.2025.08.014_bib99","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/ijmm.IJMM_15_414","article-title":"Prothrombotic state in HIV: a study on protein C, protein S, homocysteine and correlation with CD4 counts","volume":"36","author":"Khare","year":"2018","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.jtha.2025.08.014_bib100","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.4102\/sajhivmed.v22i1.1253","article-title":"Derangement of protein S and C4b-binding protein levels as acquired thrombophilia in HIV-infected adult Nigerians","volume":"22","author":"Bello","year":"2021","journal-title":"South Afr J HIV Med"},{"key":"10.1016\/j.jtha.2025.08.014_bib101","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/QAI.0000000000002994","article-title":"Total plasma protein S is a prothrombotic marker in people living with HIV","volume":"90","author":"Sim","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jtha.2025.08.014_bib102","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.virol.2017.12.025","article-title":"Protein S and Gas6 induce efferocytosis of HIV-1-infected cells","volume":"515","author":"Chua","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.jtha.2025.08.014_bib103","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1182\/bloodadvances.2021005836","article-title":"Antithrombin protects against Plasmodium falciparum histidine-rich protein II-mediated inflammation and coagulation","volume":"6","author":"Biswas","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.08.014_bib104","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/jth.15133","article-title":"Activated protein C and PAR1-derived and PAR3-derived peptides are anti-inflammatory by suppressing macrophage NLRP3 inflammasomes","volume":"19","author":"Healy","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.08.014_bib105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13567-021-00908-y","article-title":"Expression analysis of tissue factor pathway inhibitors TFPI-1 and TFPI-2 in Paralichthys olivaceus and antibacterial and anticancer activity of derived peptides","volume":"52","author":"Wang","year":"2021","journal-title":"Vet Res"},{"key":"10.1016\/j.jtha.2025.08.014_bib106","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.fsi.2020.01.057","article-title":"TC26, a teleost TFPI-1 derived antibacterial peptide that induces degradation of bacterial nucleic acids and inhibits bacterial infection in vivo","volume":"98","author":"Su","year":"2020","journal-title":"Fish Shellfish Immunol"},{"key":"10.1016\/j.jtha.2025.08.014_bib107","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17227-7","article-title":"The relationship between antithrombin administration and inflammation during veno-venous ECMO","volume":"12","author":"Panigada","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2025.08.014_bib108","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.3390\/jcm12113822","article-title":"Effects of antithrombin on persistent inflammation, immunosuppression, and catabolism syndrome among patients with sepsis-induced disseminated intravascular coagulation","volume":"12","author":"Kanda","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jtha.2025.08.014_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/ams2.648","article-title":"Influence of high-dose antithrombin on platelet function and blood coagulation","volume":"8","author":"Miike","year":"2021","journal-title":"Acute Med Surg"},{"key":"10.1016\/j.jtha.2025.08.014_bib110","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1055\/s-0044-1786754","article-title":"Heparins May Not Be the Optimal anticoagulants for sepsis and sepsis-associated disseminated intravascular coagulation","volume":"50","author":"Iba","year":"2024","journal-title":"Semin Thromb Hemost"},{"issue":"1_suppl","key":"10.1016\/j.jtha.2025.08.014_bib111","doi-asserted-by":"crossref","first-page":"66S","DOI":"10.1177\/02676591241237637","article-title":"The role of inflammation and antithrombin supplementation on thromboelastographic parameters during veno-venous ECMO for respiratory failure","volume":"39","author":"Meli","year":"2024","journal-title":"Perfusion"},{"key":"10.1016\/j.jtha.2025.08.014_bib112","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214196","article-title":"3K3A-Activated protein C prevents microglia activation, inhibits NLRP3 inflammasome and limits ocular inflammation","volume":"23","author":"Palevski","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2025.08.014_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310642","article-title":"3K3A-Activated protein C inhibits choroidal neovascularization growth and leakage and reduces NLRP3 inflammasome, IL-1\u03b2, and inflammatory cell accumulation in the retina","volume":"24","author":"Weinberger","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2025.08.014_bib114","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1134\/S0006297919120113","article-title":"DNA aptamers to thrombin exosite I. Structure-function relationships and antithrombotic effects","volume":"84","author":"Spiridonova","year":"2019","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.jtha.2025.08.014_bib115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/vox.13567","article-title":"New plasma protein C and protein S concentrate: a synergy for therapeutic purposes","volume":"119","author":"Mori","year":"2024","journal-title":"Vox Sang"},{"key":"10.1016\/j.jtha.2025.08.014_bib116","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29380","article-title":"Successful perioperative management using prothrombin complex concentrates in patients with severe congenital protein C deficiency","volume":"69","author":"Inoue","year":"2022","journal-title":"Pediatr Blood Cancer"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625005409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625005409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T14:00:07Z","timestamp":1766152807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625005409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":115,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1538783625005409"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.08.014","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternate functions of physiological anticoagulants","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}